Numbers

Claude View

Micron trades at ~8x forward earnings on consensus FY2026 EPS of $57.58, making it the cheapest large-cap semiconductor stock by a wide margin. The market is pricing in a severe cyclical earnings decline from the current $12.07 quarterly EPS. The single metric most likely to rerate or derate this stock is gross margin trajectory – if margins settle above 50% rather than reverting to the historical 35% mid-cycle, the stock is deeply undervalued.

Valuation Snapshot

Price (Apr 14)

$465.66

Trailing P/E

22.0

Forward P/E (FY26E)

8.1

Market Cap ($B)

525.7

The gap between trailing P/E (22x) and forward P/E (8x) captures the market's central dilemma: consensus expects EPS to nearly triple from $21 TTM to $58 in FY2026, but the low forward multiple says the market does not believe those earnings are sustainable.

Revenue and Earnings Power

From a $5.8B loss in FY2023 to $8.5B net income in FY2025, Micron's earnings swing illustrates extreme operating leverage. Revenue grew 141% while net income swung $14.4B – every incremental revenue dollar above the ~$20B breakeven falls through at very high margins.

Q2 FY2026 is extraordinary: revenue nearly doubled sequentially to $23.9B, gross margins expanded 18 points to 74.4%, and EPS hit $12.07 – more than the entire FY2025 combined. Management guided Q3 FY2026 to set new records, with gross margins expected around 81%.

Q2 FY2026 revenue of $23.9B exceeded Q1 guidance of $18.7B by 28%. The earnings beat was 45% above guidance. This is HBM-driven demand acceleration, not normal seasonal strength.

Analyst Estimates vs Cycle History

FY2026E Revenue ($M)

$109,751

FY2026E EPS

$57.58

FY2027E P/E

4.8

Consensus expects revenue to nearly triple from FY2025 to FY2026 ($37B to $110B) and grow another 59% to $174B in FY2027 before flattening. The FY2027-to-FY2028 EPS plateau ($96 both years) signals the market expects the super-cycle to stabilize, not collapse. At $466, the stock trades at 4.8x FY2027 consensus – either estimates will be cut or the stock is deeply mispriced.

Cash Generation and Capital Intensity

FY2025 FCF ($M)

$1,668

Capex/Revenue

42%

Cash Balance ($M)

$9,642

Micron consumed nearly all operating cash flow in capex over FY2023-FY2025, turning FCF positive only in FY2025 at $1.7B. The company guides FY2026 capex to ~$20B for HBM capacity and US fabs under the CHIPS Act. As revenue scales toward $110B+, capex intensity should decline below 20% of revenue, unlocking substantial FCF. Management signaled confidence with a 30% dividend increase in Q2 FY2026.

Micron paid zero in share buybacks in FY2025 and only $522M in dividends. Every incremental dollar is going into capacity expansion. This is a growth reinvestment story, not a capital return story -- for now.

Balance Sheet Strength

Debt/Equity

15%

Interest Coverage

Current Ratio

2.9

ROIC

32%

The balance sheet is conservatively managed. Net debt fell from $3.8B to $2.5B despite massive capex. Debt-to-equity declined from 0.28x to 0.22x. With interest coverage of 80x and $9.6B in cash, there is no balance sheet stress. ROIC of 32% is exceptional for a capital-intensive manufacturer and well above the through-cycle average of 10-15%.

Stock Price: $71 to $466 in Twelve Months

The stock rose 556% in twelve months. The steepest acceleration came after Q1 FY2026 earnings (December 2025) and the Q2 FY2026 blowout (March 2026). The March selloff to $322 – triggered by Google's TurboQuant announcement and tariff fears – was bought aggressively, with the stock recovering to $466 within three weeks.

Peer Valuation Comparison

No Results

Micron sits in the bottom-right: fastest growth, lowest valuation. The PEG ratio of 0.22 versus NVDA's 1.92 quantifies the discount. The market is either underpricing Micron's growth durability or correctly pricing the cyclical risk premium that memory has always carried.

The Critical Chart: Where Do Margins Settle?

No Results

This table explains the stock. At historical mid-cycle margins (35%), Micron earns ~$15 EPS and trades at 31x -- expensive. At the HBM-adjusted new mid-cycle (50%), it earns ~$35 and trades at 13x -- reasonable. At consensus FY2027, it trades under 5x -- absurdly cheap if sustainable. The market is pricing somewhere between the first two scenarios.

Summary

The numbers confirm Micron's transformation from a pure commodity cyclical into a structurally higher-margin business. Q2 FY2026 results – 74% gross margin, $12 EPS, $24B revenue – are unprecedented in memory industry history. The balance sheet is clean, ROIC is 32%, and the capex cycle should begin yielding FCF as revenue scales.

The numbers contradict the market's implicit assumption of full margin reversion. Consensus estimates $96 EPS for FY2027, yet the stock trades at only 22x trailing – the market is pricing either steep estimate cuts or a cyclical collapse that HBM supply constraints may prevent.

Watch next quarter: Q3 FY2026 gross margin guidance of ~81% is the test. Any sequential compression would confirm the cycle-peak thesis. Sustained margins above 70% would force upward estimate revisions and likely trigger a re-rating toward 12-15x forward earnings.